Nutraceuticals In Treatment Of Parkinson’s Disease

Authors

  • P. Selvakumar Krishna pharmacy college, Kottaimedu, Trichy-621105, Tamilnadu, India.
  • P. Kavitha Krishna pharmacy college, Kottaimedu, Trichy-621105, Tamilnadu, India.
  • N. Sivagurunathan Krishna pharmacy college, Kottaimedu, Trichy-621105, Tamilnadu, India.
  • K. Yuvaraj Krishna pharmacy college, Kottaimedu, Trichy-621105, Tamilnadu, India.
  • S. Sukumar Krishna pharmacy college, Kottaimedu, Trichy-621105, Tamilnadu, India.

Keywords:

L-dopa, Parkinson’s disease, tissue

Abstract

Parkinson’s disease is one of the most important age related disorder in the world. They progressively lost their dopaminergic neurons in the substantia nigra. Low level of dopamine cause dyskinesia, cognitive deflicits and depression. Several factors involve in the Parkinson’s disease conditions such as distrupt in anti-oxidant pathway and mitochondrial dysfunction. It is followed by formation of lewy bodies cause CNS damage. In this article we tries to improve the utilization of plant resources in the parkinson’s diease. Nutraceutical plays an significant role in the Neuro-degenerative diseases. They are low toxic and better therapeutic action and also improve the patients’s quality of life. Some of the nutraceutical provide significant results in experimental models and pre-clinical studies. We explain the present and future prospects of nutraceuticals in Parkinson’s disease. We importantly focused in mucuna pruriens, nigella sativa, vicia faba, curcumin and gallic acid in parkinson’s disease.            

Dimensions

Published

2024-11-28